Abstract

Any value measure must be used in a way appropriate for decision making. This session focused on value measures appropriate for specific decision and pricing contexts. This session featured presentations by Adrian Towse, who provided his thinking about indication-based pricing; Liz Spurgin, who discussed the valuation of medical devices and how it differs from the pharmaceutical market; and Patricia Danzon, who discussed affordability as an expanded measure of value. Sachin Kamal-Bahl, moderated this session.